CHGX — Chitogenx Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual balance sheet for Chitogenx, fiscal year end - January 31st, CAD millions except per share, conversion factor applied.
2020 January 31st | C2021 January 31st | 2022 January 31st | 2023 January 31st | 2024 January 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | Interim Report | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.302 | 2.38 | 0.313 | 0.108 | 0.035 |
| Net Total Receivables | 0.375 | 0.203 | 0.289 | 0.166 | 0.089 |
| Prepaid Expenses | |||||
| Total Current Assets | 0.741 | 2.84 | 0.722 | 0.396 | 0.234 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.15 | 0.073 | 0.069 | 0.043 | 0.033 |
| Net Intangible Assets | |||||
| Total Assets | 1.29 | 3.28 | 1.12 | 0.738 | 0.534 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.64 | 2.31 | 1.87 | 7.22 | 3.27 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 3.69 | 5.08 | 8.23 | 10.6 | 6.71 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -2.4 | -1.8 | -7.1 | -9.84 | -6.18 |
| Total Liabilities & Shareholders' Equity | 1.29 | 3.28 | 1.12 | 0.738 | 0.534 |
| Total Common Shares Outstanding |